News Releases | Olink Holding AB

Date	Title
Jul 27, 2021	Olink: CORAL to use the Olink Proteomics platform to identify novel protein biomarkers and biological mechanisms for neurological diseases
Jul 21, 2021	UK Biobank-PPP expands proteomics study of 53,000 participants to Olink Explore 3072
Jul 14, 2021	Olink Holding AB (publ) Announces Pricing of Public Offering of American Depositary Shares by Selling Shareholders
Jul 13, 2021	Olink enters into an agreement with deCODE genetics for early access to the Olink Explore 3072 Platform
Jul 12, 2021	Olink announces preliminary financial results for the second quarter 2021
Jul 12, 2021	Olink Holding AB (publ) Launches Public Offering of American Depositary Shares by Selling Shareholders
Jun 23, 2021	Olink announces the new Explore 3072 high throughput proteomics platform, offering uncompromised data quality with coverage of all major biological pathways
Jun 15, 2021	Olink: SCALLOP launches clinical trial arm to uncover next level of drug target insights from proteomic profiling
Jun 02, 2021	Announcing Olink Signature Q100: facilitating access for researchers to Olink technology with a benchtop system dedicated to multiplex protein biomarker measurement
May 25, 2021	Olink to present at the Goldman Sachs 42nd Annual Global Healthcare Conference